Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Stanziola, A.A.; Calabrese, C.; Terracciano, R.; Longhini, F.; Vatrella, A.
Novel Biological Therapies for Severe Asthma Endotypes. Biomedicines 2022, 10, 1064.
https://doi.org/10.3390/biomedicines10051064
AMA Style
Pelaia C, Pelaia G, Crimi C, Maglio A, Stanziola AA, Calabrese C, Terracciano R, Longhini F, Vatrella A.
Novel Biological Therapies for Severe Asthma Endotypes. Biomedicines. 2022; 10(5):1064.
https://doi.org/10.3390/biomedicines10051064
Chicago/Turabian Style
Pelaia, Corrado, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Anna Agnese Stanziola, Cecilia Calabrese, Rosa Terracciano, Federico Longhini, and Alessandro Vatrella.
2022. "Novel Biological Therapies for Severe Asthma Endotypes" Biomedicines 10, no. 5: 1064.
https://doi.org/10.3390/biomedicines10051064
APA Style
Pelaia, C., Pelaia, G., Crimi, C., Maglio, A., Stanziola, A. A., Calabrese, C., Terracciano, R., Longhini, F., & Vatrella, A.
(2022). Novel Biological Therapies for Severe Asthma Endotypes. Biomedicines, 10(5), 1064.
https://doi.org/10.3390/biomedicines10051064